Gyros Protein Technologies adds Gyrolab® Biomarker Kits to expand range of ready-to-use kits and reagents
Gyros Protein Technologies AB, a leading provider of peptide synthesizers and reagents and a pioneer in automated nanoliter-scale immunoassays, today introduced Gyrolab® Human Cytokine Kit Reagents, the first in a range of new biomarker kits. These include fiv
Blood thinning drug to treat recovery from severe Covid is not effective
A UK-wide trial, led by Addenbrooke’s Hospital and the University of Cambridge, has found that a drug used to reduce the risk of blood clots does not help patients recovering from moderate and severe Covid – despite this approach being offered to patients.
Arecor granted key patent In Japan and South Korea to protect proprietary insulin products At247 and At278
The granted patents further strengthen the Group’s extensive patent portfolio protecting its proprietary Arestat™ technology and diabetes product portfolio
Pure wins UK Employer of the Year Gold from Investors in People
The Pure Resourcing Solutions team is thrilled to announce that they have been awarded the Investors in People’s (IIP) UK Employer of the Year Gold award (50–249 employees).
Arecor to commence second clinical trial with at278 ultra-concentrated ultra-rapid acting insulin candidate for type 2 diabetes
Clinical trial application approved - EU Phase I clinical trial expected to commence in December 2022
Community nurses get a boost from new kit bags
Community nursing teams at Cambridgeshire and Peterborough NHS Foundation Trust (CPFT) have won national funding for new branded bags to organise essential kit for care visits and save them extra time and travel.
Beatrix Fogler joins Salus Wellness this month
The team are very pleased to announce that Beatrix Fogler joined Salus Wellness Clinics.
Multi-award-winning Team Consulting to headline Cambridge Network’s latest Virtual Jobs & Careers Fair
Cambridge Network unveils Team Consulting as headline sponsor of its latest December 2022 Virtual Jobs & Careers Fair – 9th December 2022.
New hope for kidney cancer treatment using existing drugs
The most comprehensive study of kidney cancer at single-cell level has discovered a potential drug target to treat renal cell carcinoma, a cancer with a high mortality rate that is hard to detect. Researchers from the Wellcome Sanger Institute, the University of Cambridge and Cambridge University Hospitals identified immune cells known as macrophages that express the gene IL1B as crucial to…
Career change can be scary, but branching out could be the making of you
Career change can be scary, but it can also be an incredible opportunity to re-evaluate what it is you really want from your career. Whether you’ve been made redundant, or decided to leave your job of your own accord, managing a major change in your career can be challenging.
How cyber security threats might affect your business
A new report published by Beazley, highlights just how many potential cyber threats organisations could be exposed to on a daily basis.
Sartorius BIA Separations and Exopharm sign joint research agreement to develop integrated technology for large-scale exosome production
Sartorius BIA Separations (BIA), a leading bio-chromatography company, now part of the international life science group Sartorius, and Exopharm Ltd.
The Native Antigen Company strengthens senior team to support growing product portfolio
The Native Antigen Company (part of LGC Clinical Diagnostics), one of the world’s leading suppliers of reagents that enables research into vaccines and diagnostics for emerging and endemic infectious diseases, today announced two key appointments to its management team.
Optibrium appoints Ian Smith as Chief Technology Officer
As CTO, Ian will lead the Software Engineering, DevOps and Quality Assurance teams, driving the scale-up of the Company’s infrastructure and managing the expanding portfolio of products and development projects.
2022 Deloitte Tech Fast 50 ranking
Deloitte announces the winners of the 2022 UK Technology Fast 50 awards. The awards recognise and rank the 50 fastest-growing technology companies in the UK, based on average revenue growth over a three-year period, and are sponsored by Multiverse, Oracle NetSuite and BGF.
Fujifilm invests $188 million in new cell culture media manufacturing facility
FUJIFILM Corporation (President and CEO, Representative Director: Teiichi Goto) today announced a $188 million investment to establish a cell culture media manufacturing facility in Research Triangle Park (RTP), North Carolina, USA.
Babraham Research Campus Ltd appoints Kathryn Chapman as Director of Science & Entrepreneurship
Babraham Research Campus Ltd, which is responsible for the development and management of the Babraham Research Campus is delighted to announce the appointment of Dr Kathryn Chapman to the newly created role of Director, Science & Entrepreneurship.
CMR Surgical announces more than 100 Versius systems installed globally
CMR is delivering on its commercial strategy of rapid global expansion with systems installed across the world and more than 5,000 clinical cases performed.
Computational chemistry news from Cresset, November 2022
Computational chemistry news including new science for rapid exploration and analysis of lead compounds and ligand series, and effective communication of project results, ready-to-use Flare Python Cookbook recipes include the ability to focus on results relevant for your project, quickly explore
The Native Antigen Company introduces new range of influenza antigens
The Native Antigen Company (part of LGC Clinical Diagnostics), one of the world’s leading suppliers of reagents that enables research into vaccines and diagnostics for emerging and endemic infectious diseases, today announced the commercial launch of its latest range of influenza antigens for the
Five Alarm Bio in the Press
Five Alarm Bio has anti-ageing drug agenda firmly in its sights
Arecor announces exclusive specialty hospital formulation collaboration
Arecor Therapeutics plc (AIM: AREC), the biopharmaceutical group advancing today’s therapies to enable healthier lives, today announces that it has signed an exclusive formulation study collaboration with the pharmaceutical division of one of the world’s largest chemicals
Novel approaches to recruitment for early-stage Biotechs
New brief guide on what to look for in a recruiter, how to make it work for you and what new models are out there
World Orphan Drug Congress Europe 2022
CRA is a proud sponsor of the congress.